LUMOS PHARMA INC - Common Stock (LUMO)

Historical Holders from Q1 2020 to Q1 2025

Symbol
LUMO on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
8,122,625
All holders as of 31 Mar 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LUMOS PHARMA INC - Common Stock (LUMO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLS FARGO & COMPANY/MN 0.8% $251,476 64,981 Wells Fargo & Company 30 Sep 2024

Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$387 0
2024 Q4 0 $0 -$8,080,749 0
2024 Q3 2,088,150 $8,080,749 +$437,841 $3.87 28
2024 Q2 2,077,959 $4,820,513 -$285,684 $2.32 35
2024 Q1 2,176,429 $6,137,561 -$538,428 $2.82 35
2023 Q4 2,367,345 $7,518,364 -$233,151 $3.18 36
2023 Q3 2,440,661 $8,054,168 +$72,858 $3.3 33
2023 Q2 2,393,809 $7,897,148 +$530,492 $3.3 34
2023 Q1 2,232,913 $7,403,267 -$643,185 $3.31 34
2022 Q4 2,360,021 $8,575,404 -$534,037 $3.61 35
2022 Q3 2,511,198 $22,225,824 +$1,762,681 $8.85 29
2022 Q2 2,324,202 $17,893,638 -$854,512 $7.7 32
2022 Q1 2,481,066 $23,335,869 -$1,872,873 $9.4 31
2021 Q4 2,701,081 $18,721,286 -$1,209,298 $6.93 30
2021 Q3 2,865,997 $27,253,391 -$3,434,888 $9.51 30
2021 Q2 3,202,560 $32,064,510 -$1,155,624 $10 33
2021 Q1 3,314,846 $38,788,642 -$8,023,294 $11.7 33
2020 Q4 3,769,462 $134,566,447 +$4,555,911 $35.71 43
2020 Q3 3,634,580 $50,231,000 +$825,027 $13.82 33
2020 Q2 3,561,990 $58,740,000 +$5,044,218 $16.49 36
2020 Q1 3,277,359 $27,859,000 +$27,733,000 $8.5 39